Comparative study of antifibrinolytic drugs in orthotopic liver transplantation

被引：10

作者：

Dalmau, A ^{[1
]}

Sabaté, A ^{[1
]}

Acosta, F ^{[1
]}

Garcia-Huete, L ^{[1
]}

Koo, M ^{[1
]}

Reche, M ^{[1
]}

Rafecas, A ^{[1
]}

Figueras, J ^{[1
]}

Jaurrieta, E ^{[1
]}

机构：

[1] Univ Barcelona, CSU Bellvitge, Liver Transplant Unit, E-08007 Barcelona, Spain

来源：

TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 06期

关键词：

D O I：

10.1016/S0041-1345(99)00378-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2361 / 2362

页数：2

共 6 条

[1] Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation [J].

Boylan, JF ;

Klinck, JR ;

Sandler, AN ;

Arellano, R ;

Greig, PD ;

Nierenberg, H ;

Roger, SL ;

Glynn, MFX .

ANESTHESIOLOGY, 1996, 85 (05) :1043-1048

[2]

KANG Y, 1987, ANESTHESIOLOGY, V66, P766

[3] Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation [J].

Kaspar, M ;

Ramsay, MAE ;

Nguyen, AT ;

Cogswell, M ;

Hurst, G ;

Ramsay, KJ .

ANESTHESIA AND ANALGESIA, 1997, 85 (02) :281-285

[4]

KASPAR M, 1997, ANESTHES ANALGES, V85, P285

[5]

MCSORLEY MW, 1991, TRANSPLANT P, V23, P1941

[6]

YASSEN K, 1993, CLIN TRANSPLANT, V7, P453

← 1 →